RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Gritstone bio Stock

Gritstone bio Dividend 2024

Gritstone bio Dividend

0 USD

Gritstone bio Dividend yield

Ticker

GRTS

ISIN

US39868T1051

WKN

A2N4RX

How much dividend does Gritstone bio 2024 pay?

According to the latest status from September 2024, Gritstone bio paid a total of 0 USD per share in dividends within the last 12 months. With the current Gritstone bio price of 0.61 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Gritstone bio Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Gritstone bio Dividend Safe?

Gritstone bio has been increasing the dividend for 0 years.

Over the past 8 years, Gritstone bio has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Gritstone bio's Dividend Distributions

Gritstone bio’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Gritstone bio's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Gritstone bio's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Gritstone bio’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Gritstone bio Aktienanalyse

What does Gritstone bio do?

Gritstone Oncology Inc. is a biotechnology company based in California, USA, that develops innovative cancer immunotherapies. It was founded in 2015 by Dr. Andrew Allen and Dr. Alex Chaudhuri, and has been listed on the Nasdaq stock exchange with the ticker "GRTS" since 2018. The founders previously worked in the field of immunotherapy at Roche and Takeda and recognized the potential of personalized cancer therapies using immunology and cancer genomics technologies. With funding of over $220 million from investors such as Versant Ventures, The Column Group, and Frazier Healthcare Partners, the company has experienced strong growth in recent years. Gritstone Oncology follows an integrated business model that includes innovative platform technologies for identifying tumor antigens and developing personalized immunotherapies. The company uses advanced sequencing technologies and data analysis methods to detect individual cancer mutations and develop tailored therapies. Gritstone Oncology has two main product categories: cancer immunotherapies and cancer diagnostics. The company is developing various immunotherapies for the treatment of cancer, including a novel SARS-CoV-2/COVID-19 vaccine based on the same platform as their cancer immunotherapies. Additionally, Gritstone Oncology has developed a proprietary platform for the development of bispecific antibodies, which can simultaneously target two different objectives. They are also developing personalized immunotherapies that specifically target an individual patient's cancer mutations. The company also offers diagnostic tests to identify cancer mutations and determine therapeutic options. These include GPS Cancer, a genomic test that enables personalized cancer diagnosis and therapy, and SLATE, a diagnostic test that analyzes the immune status of tumor cells and surrounding tissues to develop personalized immunotherapy. In conclusion, Gritstone Oncology has become a leading company in the field of personalized cancer immunotherapy. It has strong growth potential due to its innovative technologies and research, as well as its highly experienced leadership and employees. The company will continue to play a critical role in cancer research and therapy and has the potential to improve the lives of millions of people worldwide. Gritstone bio is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Gritstone bio stock

How much dividend does Gritstone bio pay?

Over the past 12 months, Gritstone bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Gritstone bio is expected to pay a dividend of 0 USD.

What is the dividend yield of Gritstone bio?

The current dividend yield of Gritstone bio is .

When does Gritstone bio pay dividends?

Gritstone bio pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gritstone bio?

Gritstone bio paid dividends every year for the past 0 years.

What is the dividend of Gritstone bio?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Gritstone bio located?

Gritstone bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gritstone bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gritstone bio from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Gritstone bio pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Gritstone bio in the year 2023?

In the year 2023, Gritstone bio distributed 0 USD as dividends.

In which currency does Gritstone bio pay out the dividend?

The dividends of Gritstone bio are distributed in USD.

Andere Kennzahlen von Gritstone bio

Our stock analysis for Gritstone bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gritstone bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.